Shionogi Receives Approval of Additional Dosage and Administration of Carbapenem Antibiotic Products: Finibax® 0.25g IV Solution and Finibax® 0.25g IV Solution Kit
This website uses cookies for analytics and functionality purposes. To change your cookie settings or find out more, click here.
If you continue browsing our website, you accept these cookies.
